← Leaderboards
Evelyn Nunez
Tufts Medical Center
$42,739
Attributed
$42,739
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$42,739 · 1
By mechanism
M01$42,739 · 1
Top collaborators
No co-investigators on record.
Most similar at Tufts Medical Center
Same institution · by research overlap
- Francine M Foss$122,062
- John K Erban$2,404,976
- David Schenkein$42,739
- Shirley Tsunoda$85,478
- Domenic Anthony Ciraulo$7,276,925
Others in their field
Top investigators on “Bryostatin”
- Paul Wender · University Of California Los Angeles$14,065,471
- Jerome A. Zack · University Of California Los Angeles$6,137,468
- George R Pettit · Arizona State University-Tempe Campus$6,116,526
- Gary E Keck · University Of Utah$5,459,045
- Steven Grant · Virginia Commonwealth University$5,152,418
- Trevor P. Castor · Aphios Corporation$5,003,731
Research focus
BryostatinChemical HypersensitivityClinical ResearchClinical Trial Phase ICytotoxicityHuman SubjectHuman Therapy EvaluationNeoplasm /Cancer ChemotherapyNeoplasm /Cancer Relapse /RecurrenceOvary NeoplasmsPeritoneum NeoplasmPlatinum
Grant awards (3)
BRYOSTATIN IN RECURR OR PERSIST PLATINUM SENSITIVITY OVARIAN OR PERITONEAL CANCER$0
M01 · FY2002 · RR
BRYOSTATIN IN RECURR OR PERSIST PLATINUM SENSITIVITY OVARIAN OR PERITONEAL CANCER$0
M01 · FY2001 · RR
BRYOSTATIN IN RECURR OR PERSIST PLATINUM SENSITIVITY OVARIAN OR PERITONEAL CANCER$42,739
M01 · FY2000 · RR